Wockhardt-made drug in U.S. FDA recall action

U.S.-based distributor PD-Rx Pharmaceuticals has been asked to recall more than 60,000 bottles of bacterial infection treatment azithromycin tablets made by Mumbai-based Indian drugmaker Wockhardt, the Economic Times reports. The recall of 62,555 bottles was made as a follow-up to a Wockhardt voluntary recall made in April 29 of last year, the Economic Times said, citing a U.S. Food and Drug Administration Enforcement Report. In June 2015, Wockhardt was hauled up for its third voluntary recall in as many months. The company has faced FDA bans on drugs manufactured at its two facilities in Aurangabad, India--one in Chikalthana and the other in Waluj. Report

Suggested Articles

New legal complaints focus on eight Sanofi executives, most of them with local management titles, and 15 managers at distributor Zuellig Pharma.

A self-proclaimed former employee at Novartis’ Beijing office accused the Swiss drugmaker of expensing fake academic events to offer kickbacks to doctors.

A decree includes tax incentives for certain generic drugmakers and uniform insurance standards that apply to both branded drugs and generics.